Diabetes advocacy group discourages use of compounded GLP-1 drugs
BioPharma Drive: Drug Pricing
DECEMBER 2, 2024
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.
Let's personalize your content